LAKE OSWEGO, Ore., Aug. 28, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and CEO, will present a corporate overview at BioCentury's 2012 NewsMakers in the Biotech Industry conference. The presentation will take place on Friday, September 7, 2012 at 11:30 a.m. EDT at the Millennium Broadway Hotel and Conference Center in New York, NY.
The presentation will be webcast and available on the Company's website at http://investors.galenabiopharma.com/events.cfm .
About Galena BiopharmaGalena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com . The Galena Biopharma, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10647
CONTACT: Madeline Hatton Toll free: +1 (855) 855-GALE (4253), ext. 109 firstname.lastname@example.org or Remy Bernarda IR Sense, LLC +1 (415) 203-6386 email@example.com